Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ARGELIA CLEMENTINA DOUGLAS

Allopathic & Osteopathic Physicians Pediatrics

NPI
1649360439
CMS profile
165150
Location
EDINBURG, TX

General Payments · PY2018–2024

$3,004.65

  • Reported across 77 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$771.81

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $771.81 17

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $907.95 23
PY2019 $610.51 12
PY2020 $57.71 4
PY2021 $83.15 6
PY2022 $54.32 4
PY2023 $519.20 11
PY2024 $771.81 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $23.75 08/05/2024 Food and Beverage Undisputed 01/23/2026 1125169504 CMS
Abbott Laboratories $21.87 10/25/2024 Food and Beverage Undisputed 01/23/2026 1125169502 CMS
Amgen Inc. $127.21 01/23/2024 Food and Beverage Undisputed 01/23/2026 1111565651 CMS
Evofem Biosciences, Inc. $16.52 02/06/2024 Food and Beverage Undisputed 01/23/2026 1091273505 CMS
GlaxoSmithKline, LLC. $20.31 09/04/2024 Food and Beverage Undisputed 01/23/2026 1116367251 CMS
Kowa Pharmaceuticals America, Inc. $15.14 11/05/2024 Food and Beverage Undisputed 01/23/2026 1113465643 CMS
Kowa Pharmaceuticals America, Inc. $19.36 11/06/2024 Food and Beverage Undisputed 01/23/2026 1113465645 CMS
Merck Sharp & Dohme LLC $16.96 05/28/2024 Food and Beverage Undisputed 01/23/2026 1141975264 CMS
Merck Sharp & Dohme LLC $19.91 09/05/2024 Food and Beverage Undisputed 01/23/2026 1141901924 CMS
Optinose US, Inc. $13.75 06/25/2024 Food and Beverage Undisputed 01/23/2026 1142191180 CMS
Optinose US, Inc. $25.56 06/25/2024 Food and Beverage Undisputed 01/23/2026 1142191290 CMS
Optinose US, Inc. $19.60 07/12/2024 Food and Beverage Undisputed 01/23/2026 1142191242 CMS
Optinose US, Inc. $124.72 07/31/2024 Food and Beverage Undisputed 01/23/2026 1142191288 CMS
Optinose US, Inc. $17.03 08/10/2024 Food and Beverage Undisputed 01/23/2026 1142191260 CMS
Optinose US, Inc. $134.00 09/27/2024 Food and Beverage Undisputed 01/23/2026 1142191286 CMS
Optinose US, Inc. $140.00 10/31/2024 Food and Beverage Undisputed 01/23/2026 1142191284 CMS
Tris Pharma Inc $16.12 05/01/2024 Food and Beverage Undisputed 01/23/2026 1147212789 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.